[ET Net News Agency, 31 March 2023] Credit Suisse lowered its target price for Innovent
(01801) to HK$52 from HK$57 and maintained its "outperform" rating.
The research house said it now estimates FY23 topline growth at 33%. After model
adjustment, the FY23/24E EPS is lower by 15%/59%. (RC)